X Financial Disclaimer | | Certain statements in this presentation, and other statements that the Company may m | | --- | --- | | | forward-lookingstatements within the meaning of Section 27A of the Securities Act and | | | 21E of the Securities Exchange Act of 1934, as amended. These statements reflect the | | | intent, beliefs or current expectations about the future. These statements can be recogn | | s or | use of words such as "expects," "plans," "will," "estimates," "projects," "intends," "anticip | | ...

Core Insights - Kolibri Global Energy reported a 15% increase in production to an average of 4,013 BOEPD in 2025, achieving a compound annual growth rate of 35% over the last three years [2][11] - The company generated $56.9 million in net revenue and $42.1 million in Adjusted EBITDA for 2025, reflecting a decrease of 3% and 4% respectively compared to 2024 [3][10] - The total proved reserves increased by 1% to 40.8 million barrels of oil equivalent, with a net present value (NPV10) of $440.7 million [3][10] Financial Performance - Net income for 2025 was $15.5 million ($0.44 per basic share), down from $18.1 million ($0.51 per basic share) in 2024, attributed to lower average prices and increased operating expenses [3][6] - Average production costs per barrel decreased by 1% to $7.33 per BOE in 2025, while netback from operations fell by 18% to $31.49 per BOE due to lower average prices [3][12] - Capital expenditures doubled to $62.6 million in 2025, driven by increased drilling activity and costs associated with operational challenges [14] Production and Revenue Breakdown - Oil revenues before royalties decreased by 8% to $63.0 million, while natural gas revenues increased by 126% to $3.9 million due to higher production and prices [10] - The average price per barrel fell by 16% to $49.22, impacting overall revenue despite increased production [3][10] - The company reported a 15% increase in production volume, with the new wells contributing significantly to the output [11][18] Operational Highlights - The company faced operational delays due to a drill pipe failure, which affected the fourth quarter production [4] - New wells that began production at the end of 2025 are expected to enhance cash flow and production figures in 2026 [4][5] - The 2026 drilling program is being finalized, with expectations for lower capital expenditures compared to 2025 [5]

Investor Presentation M a r c h 2 0 2 6 • All amounts in millions of US Dollars unless otherwise noted. • This presentation makes reference to certain non-GAAP measures, including local currency ("LC") revenue growth rate, internal revenue growth rate, Adjusted EBITDA ("AEBITDA"), Adjusted EBITDA from recurring revenue percentage, Adjusted EPS ("AEPS"), free cash flow, assets under management ("AUM") and fee-paying assets under management ("FPAUM"). Please refer to Appendix for reconciliations to the most d ...

Core Insights - U.S. Physical Therapy, Inc. reported strong financial results for the fourth quarter and full year ended December 31, 2025, with significant revenue and profit growth compared to the previous year [1][4]. Financial Highlights - Adjusted EBITDA for the year ended December 31, 2025, was $95.0 million, an increase of $13.2 million or 16.2% from $81.8 million in 2024 [3][31]. - Net income attributable to USPH shareholders for 2025 was $39.6 million, compared to $31.4 million in 2024, while earnings per share decreased to $1.42 from $1.84 due to changes in fair value of redeemable noncontrolling interests [3][31][21]. - Operating Results for 2025 was $40.0 million, up from $36.9 million in 2024, translating to $2.63 per share compared to $2.45 per share in the prior year [3][31]. Quarterly Performance - For the fourth quarter of 2025, Adjusted EBITDA was $24.8 million, a 13.5% increase from $21.8 million in the fourth quarter of 2024 [3][22]. - Net income for the fourth quarter of 2025 was $4.2 million, down from $9.2 million in the same quarter of 2024, primarily due to a net loss related to contingent earnout consideration [3][21]. - Net revenue from physical therapy operations in the fourth quarter increased by $20.0 million, or 13.0%, to $173.8 million from $153.8 million in the fourth quarter of 2024 [3][8]. Operational Metrics - Total patient visits for the fourth quarter of 2025 were 1,593,336, an 11.2% increase from 1,432,801 in the fourth quarter of 2024 [3][8]. - The average daily patient visits per clinic reached a record high of 32.7 in the fourth quarter of 2025, compared to 31.6 in the fourth quarter of 2024 [3][8]. - Industrial injury prevention services revenue for the fourth quarter was $28.9 million, an increase of 8.7% compared to $26.6 million in the fourth quarter of 2024 [3][12]. Strategic Developments - The company added 11 clinics and closed 10 in the fourth quarter of 2025, bringing the total to 780 clinics as of December 31, 2025 [3][36]. - Recent acquisitions include an eight-clinic practice and an industrial injury prevention business, expected to generate approximately $8.0 million and $7.0 million in annual revenue, respectively [3][37]. - The company announced strategic alliances with hospital systems to integrate outpatient physical therapy clinics into their clinical services networks, expected to enhance revenue and EBITDA contributions [3][39][41]. Dividend and Guidance - The Board of Directors raised the quarterly dividend rate from $0.45 to $0.46 per share, effective immediately [3][44]. - Management expects Adjusted EBITDA for 2026 to be in the range of $102.0 million to $106.0 million, including contributions from new strategic alliances and a Medicare rate increase [3][42].

Disclaimers and Non-GAAP Definitions For convenience, references in this presentation to "Ovintiv", "OVV", the "Company", "we", "us" and "our" may, where applicable, refer only to or include any relevant direct and indirect subsidiary entities and partnerships ("Subsidiaries") of Ovintiv Inc., and the assets, activities and initiatives of such Subsidiaries. The terms "include", "includes", "including" and "included" are to be construed as if they were immediately followed by the words "without limitation", ...

UL SOLUTIONS INC. Earnings Presentation Q4 2025 February 19, 2026 © 2026 UL LLC. All Rights Reserved. Forward looking statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation may be forward-looking statements. These include statements regarding UL Solutions Inc.'s (the "Company") future financial results and estimates and business prosp ...

4Q25 Earnings Call This presentation includes discussion of adjusted free cash flow, adjusted gross profit and adjusted operating income and their corresponding margins, as well as adjusted net earnings, EBITDA, adjusted EBITDA, and adjusted net diluted earnings per share. These are financial measures that were not prepared in accordance with generally accepted accounting principles in the United States (non-GAAP measures). Management believes that these non-GAAP measures are useful to investors because eac ...

2025 Fourth Quarter Results and Earnings February 10, 2026 Forward-looking and other statements in this presentation regarding our environmental and other sustainability efforts, plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and ...

The Allstate Corporation Investor Supplement Fourth Quarter 2025 The condensed consolidated financial statements and financial exhibits included herein are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The results of operations for interim periods should not be considered indicative of results to be expected for the full year. Measures used in these financial ...

Linde plc Investor Teleconference Presentation Fourth Quarter 2025 February 5, 2026 Forward-Looking Statement This document contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are identified by terms and phrases such as: anticipate, believe, intend, estimate, expect, continue, should, could, may, plan, project, predict, will, potential, forecast, and similar expressions. They are based on management's reasonable e ...